Chemical Compound Review:
Angiotensin (3S)-3-amino-3-[[(1S)-1- [[(1S)-1-[[(1S)-1...
Synonyms:
Angiotensin 2, ANGIOTENSIN II, Delivert (TN), CHEMBL408403, Ang II, ...
- Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Kim, S., Iwao, H. Pharmacol. Rev. (2000)
- TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. Schultz, J.e.l. .J., Witt, S.A., Glascock, B.J., Nieman, M.L., Reiser, P.J., Nix, S.L., Kimball, T.R., Doetschman, T. J. Clin. Invest. (2002)
- Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2. Pellieux, C., Foletti, A., Peduto, G., Aubert, J.F., Nussberger, J., Beermann, F., Brunner, H.R., Pedrazzini, T. J. Clin. Invest. (2001)
- A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy. Braun-Dullaeus, R.C., Mann, M.J., Ziegler, A., von der Leyen, H.E., Dzau, V.J. J. Clin. Invest. (1999)
- Response of proximal tubules to angiotensin II changes during maturation. Garvin, J.L., Beierwaltes, W.H. Hypertension (1998)
- Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum. Kifor, I., Williams, G.H., Vickers, M.A., Sullivan, M.P., Jodbert, P., Dluhy, R.G. J. Urol. (1997)
- Angiotensin II interacts with prostaglandin F2alpha and endothelin-1 as a local luteolytic factor in the bovine corpus luteum in vitro. Hayashi, K., Miyamoto, A. Biol. Reprod. (1999)
- Characterization of receptors for angiotensin-induced drinking and blood pressure responses in conscious rats using angiotensin analogs extended at the N-terminal. Kawabe, H., Husain, A., Khosla, M.C., Smeby, R.R., Bumpus, F.M., Ferrario, C.M. Neuroendocrinology (1986)
- AT(2) but not AT(1) receptor antagonism abolishes angiotensin II increase of the acquisition of conditioned avoidance responses in rats. Braszko, J.J. Behav. Brain Res. (2002)
- International union of pharmacology. XXIII. The angiotensin II receptors. de Gasparo, M., Catt, K.J., Inagami, T., Wright, J.W., Unger, T. Pharmacol. Rev. (2000)
- The ovarian renin-angiotensin system in reproductive physiology. Yoshimura, Y. Frontiers in neuroendocrinology. (1997)
- Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. Levy, B.I., Benessiano, J., Henrion, D., Caputo, L., Heymes, C., Duriez, M., Poitevin, P., Samuel, J.L. J. Clin. Invest. (1996)
- Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. Daugherty, A., Manning, M.W., Cassis, L.A. J. Clin. Invest. (2000)
- A central role of EGF receptor transactivation in angiotensin II -induced cardiac hypertrophy. Shah, B.H., Catt, K.J. Trends Pharmacol. Sci. (2003)
- Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo. McEwan, P.E., Gray, G.A., Sherry, L., Webb, D.J., Kenyon, C.J. Circulation (1998)
- Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Kojima, M., Shiojima, I., Yamazaki, T., Komuro, I., Zou, Z., Wang, Y., Mizuno, T., Ueki, K., Tobe, K., Kadowaki, T. Circulation (1994)
- Involvement of the area postrema in the regulation of sympathetic outflow to the cardiovascular system. Bishop, V.S., Hay, M. Frontiers in neuroendocrinology. (1993)
- Molecular basis for the modulation of native T-type Ca channels in vivo by Ca /calmodulin-dependent protein kinase II. Yao, J., Davies, L.A., Howard, J.D., Adney, S.K., Welsby, P.J., Howell, N., Carey, R.M., Colbran, R.J., Barrett, P.Q. J. Clin. Invest. (2006)
- Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule. Cheng, H.F., Becker, B.N., Burns, K.D., Harris, R.C. J. Clin. Invest. (1995)
- Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. Gibbons, G.H., Pratt, R.E., Dzau, V.J. J. Clin. Invest. (1992)
- Communication between myocytes and fibroblasts in cardiac remodeling in angiotensin chimeric mice. Matsusaka, T., Katori, H., Inagami, T., Fogo, A., Ichikawa, I. J. Clin. Invest. (1999)
- Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. Naftilan, A.J., Pratt, R.E., Dzau, V.J. J. Clin. Invest. (1989)
- Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice. Zhai, P., Yamamoto, M., Galeotti, J., Liu, J., Masurekar, M., Thaisz, J., Irie, K., Holle, E., Yu, X., Kupershmidt, S., Roden, D.M., Wagner, T., Yatani, A., Vatner, D.E., Vatner, S.F., Sadoshima, J. J. Clin. Invest. (2005)
- Role of AT1 receptors in the resetting of the baroreflex control of heart rate by angiotensin II in the rabbit. Wong, J., Chou, L., Reid, I.A. J. Clin. Invest. (1993)
- Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. Mackins, C.J., Kano, S., Seyedi, N., Schäfer, U., Reid, A.C., Machida, T., Silver, R.B., Levi, R. J. Clin. Invest. (2006)
- Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor. Siragy, H.M., Senbonmatsu, T., Ichiki, T., Inagami, T., Carey, R.M. J. Clin. Invest. (1999)
- Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. Qi, Z., Hao, C.M., Langenbach, R.I., Breyer, R.M., Redha, R., Morrow, J.D., Breyer, M.D. J. Clin. Invest. (2002)
- Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. Bruemmer, D., Collins, A.R., Noh, G., Wang, W., Territo, M., Arias-Magallona, S., Fishbein, M.C., Blaschke, F., Kintscher, U., Graf, K., Law, R.E., Hsueh, W.A. J. Clin. Invest. (2003)
- Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. Ito, S., Arima, S., Ren, Y.L., Juncos, L.A., Carretero, O.A. J. Clin. Invest. (1993)
- Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. Tsutsumi, Y., Matsubara, H., Masaki, H., Kurihara, H., Murasawa, S., Takai, S., Miyazaki, M., Nozawa, Y., Ozono, R., Nakagawa, K., Miwa, T., Kawada, N., Mori, Y., Shibasaki, Y., Tanaka, Y., Fujiyama, S., Koyama, Y., Fujiyama, A., Takahashi, H., Iwasaka, T. J. Clin. Invest. (1999)
- An unexpected role for angiotensin II in the link between dietary salt and proximal reabsorption. Thomson, S.C., Deng, A., Wead, L., Richter, K., Blantz, R.C., Vallon, V. J. Clin. Invest. (2006)
- Study of the rat adrenal renin-angiotensin system at a cellular level. Chiou, C.Y., Williams, G.H., Kifor, I. J. Clin. Invest. (1995)